Loading…
Back To Schedule
Thursday, June 18 • 9:30am - 10:30am
#411 L: Qualification and Oversight in Decentralized Trials: Practical Considerations for Clinical Operations and Quality Oversight

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-20-751-L04-P; CME 1.00; IACET 1.00; RN 1.00

In this interactive panel discussion, we will explore the critical role that providers, sponsors, and collaboratives play in driving greater adoption of decentralized clinical trials (DTs). Attendees are encouraged to engage in the discussion.

Learning Objectives

Define familiarity with the use of technologies and approaches enabling DTs; Identify challenges of vendor qualification for DTs versus traditional trials; Describe key risks when qualifying DT service providers; Characterize change management elements of success and how providers can support this effort; Describe role collaboratives and standards play in facilitating broader adoption of DTs.

Chair

Dennis Salotti, MBA, MS

Speaker

Panelist
Alison Holland

Qualification and Oversight in Decentralized Trials: Practical Considerations for Clinical Operations and Quality Oversight
Heather Zigmund, PharmD


Speakers
avatar for Dennis Salotti

Dennis Salotti

Chief Operating Officer, The Avoca Group
With 20 years in the pharmaceutical industry as a sponsor, provider, and consultant, Dennis Salotti's experience spans preclinical research, clinical operations, data management, quality assurance, eClinical, business operations, and strategic management. Prior to Avoca, he was Director... Read More →
HZ

Heather Zigmund

Senior Director, Global Head of Study Management Early Stage Development BioPhar, AstraZeneca
Heather Zigmund, Pharm.D. is Senior Director & Global Head of Study Management Early Stage Development, BioPharmaceuticals at AstraZeneca. Heather is passionate about the use of data & technology in the clinical development process and its potential to shorten development timelines... Read More →
avatar for Alison Holland

Alison Holland

Executive General Manager, Digital and Decentralized Solutions, Medable, United States
Alison (Ali) Holland is Executive GM, Digital and Decentralized Solutions at Medable and is chartered to design and expand the end-to-end capabilities needed to partially or fully virtualize clinical studies, building on the commitment to reduce clinical trial times by 50%. Ali has... Read More →

Thursday June 18, 2020 9:30am - 10:30am EDT
TBD Virtual Event Horsham, PA 19044
  02: ClinTrials -ClinOps, Forum